{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:26:35Z","timestamp":1782858395276,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Planes Nacionales de I+D+i"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Subdirecci\u00f3n General de Redes y Centros de Investigaci\u00f3n Cooperativa"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Network for Research in Infectious Diseases","award":["REIPI RD12\/0015\/0001"],"award-info":[{"award-number":["REIPI RD12\/0015\/0001"]}]},{"name":"Spanish Network for Research in Infectious Diseases","award":["RD12\/0015\/0002"],"award-info":[{"award-number":["RD12\/0015\/0002"]}]},{"name":"Spanish Network for Research in Infectious Diseases","award":["REIPI RD16\/0016\/0008"],"award-info":[{"award-number":["REIPI RD16\/0016\/0008"]}]},{"name":"Spanish Network for Research in Infectious Diseases","award":["REIPI RD16\/0016\/0009"],"award-info":[{"award-number":["REIPI RD16\/0016\/0009"]}]},{"name":"European Development Regional Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cmi.2017.09.016","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T01:02:03Z","timestamp":1506733323000},"page":"630-634","source":"Crossref","is-referenced-by-count":52,"title":["The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"24","author":[{"given":"T.","family":"Amat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guti\u00e9rrez-Pizarraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Machuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gracia-Ahufinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"P\u00e9rez-Nadales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Torre-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garnacho-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.09.016_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1469-0691.2005.01227.x","article-title":"Clinical impact and pathogenicity of Acinetobacter","volume":"11","author":"Joly-Guillou","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.09.016_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1469-0691.2002.00487.x","article-title":"Nosocomial bacteriemia due to Acinetobacter baumannii: epidemiology, clinical features and treatment","volume":"8","author":"Cisneros","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.09.016_bib3","first-page":"413","article-title":"Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection","volume":"92","author":"Jamulitrat","year":"2009","journal-title":"J\u00a0Med Assoc Thailand"},{"key":"10.1016\/j.cmi.2017.09.016_bib4","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","article-title":"Task force on management and prevention of Acinetobacter baumannii infections in the ICU","volume":"41","author":"Garnacho-Montero","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.09.016_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.09.016_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1469-0691.2006.01601.x","article-title":"Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome","volume":"13","author":"Kuo","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.09.016_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and Rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.09.016_bib8","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standard Institute","year":"2012"},{"key":"10.1016\/j.cmi.2017.09.016_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2017.09.016_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic co-morbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chron Dis"},{"key":"10.1016\/j.cmi.2017.09.016_bib11","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.09.016_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jac\/dkn128","article-title":"Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp","volume":"61","author":"Oliveira","year":"2008","journal-title":"J\u00a0Antimicrob Chemoth"},{"key":"10.1016\/j.cmi.2017.09.016_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s15010-010-0008-1","article-title":"Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes","volume":"38","author":"Routsi","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.09.016_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.eimc.2009.02.001","article-title":"Aminogluc\u00f3sidos y polimixinas","volume":"27","author":"Molina","year":"2009","journal-title":"Enferm Infec Micr Cl"},{"key":"10.1016\/j.cmi.2017.09.016_bib15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/jac\/dkq069","article-title":"Effectiveness and safety of colistin: prospective comparative cohort study","volume":"65","author":"Paul","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1517\/17425255.2011.623126","article-title":"Pharmacokinetic and pharmacodynamic evaluation of tigecycline","volume":"7","author":"Giamarellou","year":"2011","journal-title":"Expert Opin Drug Met"},{"key":"10.1016\/j.cmi.2017.09.016_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymixin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J\u00a0Antimicrob Chemoth"},{"key":"10.1016\/j.cmi.2017.09.016_bib18","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1128\/AAC.00839-16","article-title":"In\u00a0vitro synergistic activity of antimicrobial agents in combination against clinical isolates of colistin-resistant Acinetobacter baumannii","volume":"60","author":"Bae","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dki248","article-title":"Tigecycline","volume":"56","author":"Pankey","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2146\/ajhp050487","article-title":"Tigecycline: a new glycylcycline antimicrobial agent","volume":"63","author":"Kasbekar","year":"2006","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.cmi.2017.09.016_bib21","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1128\/AAC.00868-15","article-title":"Comparative evaluation of colistin susceptibility testing methods among carbapenem-nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates","volume":"59","author":"Dafopoulou","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib22","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.01084-06","article-title":"Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections","volume":"51","author":"Meagher","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib23","first-page":"273","article-title":"Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens","volume":"58","author":"Poulakou","year":"2009","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2017.09.016_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkl403","article-title":"Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose","volume":"58","author":"Rodvold","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.09.016_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-0711-8-18","article-title":"In\u00a0vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii","volume":"8","author":"Principe","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cmi.2017.09.016_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmii.2014.06.011","article-title":"Comparison of pneumonia and non-pneumonia-related Acinetobacter baumannii bacteremia: impact on empiric therapy and antibiotic resistance","volume":"48","author":"Teng","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17305293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17305293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T15:37:10Z","timestamp":1569253030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17305293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1198743X17305293"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.09.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}